- Home
- FHTX vs GPRO Comparison
FHTX vs GPRO Comparison
Compare FHTX & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- GPRO
- Stock Information
- Founded
- FHTX 2015
- GPRO 2004
- Country
- FHTX United States
- GPRO United States
- Employees
- FHTX N/A
- GPRO N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- GPRO Industrial Machinery/Components
- Sector
- FHTX Health Care
- GPRO Consumer Discretionary
- Exchange
- FHTX Nasdaq
- GPRO Nasdaq
- Market Cap
- FHTX 246.6M
- GPRO 282.4M
- IPO Year
- FHTX 2020
- GPRO 2014
- Fundamental
- Price
- FHTX $5.21
- GPRO $1.57
- Analyst Decision
- FHTX Strong Buy
- GPRO
- Analyst Count
- FHTX 6
- GPRO 0
- Target Price
- FHTX $11.83
- GPRO N/A
- AVG Volume (30 Days)
- FHTX 270.9K
- GPRO 7.4M
- Earning Date
- FHTX 11-05-2025
- GPRO 11-06-2025
- Dividend Yield
- FHTX N/A
- GPRO N/A
- EPS Growth
- FHTX N/A
- GPRO N/A
- EPS
- FHTX N/A
- GPRO N/A
- Revenue
- FHTX $24,518,000.00
- GPRO $650,751,000.00
- Revenue This Year
- FHTX $42.43
- GPRO N/A
- Revenue Next Year
- FHTX $14.77
- GPRO $9.72
- P/E Ratio
- FHTX N/A
- GPRO N/A
- Revenue Growth
- FHTX N/A
- GPRO N/A
- 52 Week Low
- FHTX $2.95
- GPRO $0.40
- 52 Week High
- FHTX $8.45
- GPRO $3.05
- Technical
- Relative Strength Index (RSI)
- FHTX 63.51
- GPRO 39.27
- Support Level
- FHTX $4.63
- GPRO $1.49
- Resistance Level
- FHTX $5.69
- GPRO $1.67
- Average True Range (ATR)
- FHTX 0.40
- GPRO 0.11
- MACD
- FHTX 0.12
- GPRO -0.02
- Stochastic Oscillator
- FHTX 74.95
- GPRO 21.70
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.